Skip to search formSkip to main contentSkip to account menu

taglutimide

Known as: 2-(2,6-dioxo-3-piperidinyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione, 2-(bicyclo(2.2.1)heptane-2-endo,3-endo-dicarboximido)glutarimide, biglumide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryPretreatment with taglutimide significantly decreased the plasma dicoumarol level and shortened the duration of… 
1979
1979
2-[Bicyclo(2,2,1)heptane-2-endo-3-endo-dicarboximido]-glutarimide (taglutimide, K-2004) proved to be a new sedative-hypnotic drug… 
1979
1979
Absorption, blood level course, renal, fecal, and biliary elimination and the metabolisation of 2-(bicyclo[2,2,1]-heptane-2-endo… 
1978
1978
The time course of the distribution of the total radioactivity, the unchanged drug, and the metabolites of biglumide (1) between… 
1977
1977
Comparison of the teratogenic and neurotoxic influence of thalidomide with the new hypnosedative preparation Biglumide (K-2004… 
1977
1977
Comparison of the teratogenic and neurotoxic influence of thalidomide with the new hypnosedative preparation Biglumide (K-2004… 
1976
1976
The embryotoxicity and teratogenicity of N-phthalyl isoglutamine (2), a metabolite of thalidomide, and of “K-2004-1c”, 2-(bicyclo…